Technical Data
A4153-04
Atrial Natriuretic Peptide, pro-, aa31-67 (ANP, ANF, Atrial natriuretic factor, Atrial natriuretic factor precursor, CDD ANF, Natriuretic Peptide Precursor A, NPPA, PND, Prepronatriodilatin)
Description:
Applications:
Suitable for use in ELISA, RIA. Other applications not tested.

Recommended Dilution:
RIA: 1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabSerum
SizeStorageShippingSourceHost
20ul-20CBlue IceHumanSheep
Concentration:
~1mg/ml
Immunogen:
Synthetic human pro-ANP (aa 31-67) polylysine conjugated (EVVPPQVLSEPNEEAGAALSPLPEVPPWTGEVSPAQR).
Purity:
Serum
Form
Supplied as a lyophilized powder. Reconstitute with sterile dH2O.
Specificity:
Recognizes synthetic human pro-Atrial Natriuretic Peptide (aa 31-67). There were no cross reactivities obtained with human pro-ANP (aa 67-98) and human pro-ANP (aa 1-30)
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Hartter E, Khalafpour S, Missbichler A, Hawa G, Woloszczuk W. Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides. Clin Chem Lab Med 2000;38:27-32.